Raymond James & Associates’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-2,202
Closed -$210K – 3696
2019
Q1
$210K Buy
2,202
+245
+13% +$30.6K ﹤0.01% 3213
2018
Q4
$243K Sell
1,957
-4,045
-67% -$666K ﹤0.01% 2991
2018
Q3
$1.47M Buy
6,002
+2,483
+71% +$574K ﹤0.01% 2004
2018
Q2
$656K Buy
3,519
+1,129
+47% +$188K ﹤0.01% 2501
2018
Q1
$294K Buy
2,390
+337
+16% +$41.1K ﹤0.01% 2893
2017
Q4
$244K Buy
+2,053
New +$226K ﹤0.01% 2944
2015
Q4
– Sell
-10,946
Closed -$531K – 2365
2015
Q3
$531K Buy
+10,946
New +$520K ﹤0.01% 1899

Other funds holding INGN

Raymond James & Associates's INGN Position: Q2 2019 in Review

Raymond James & Associates sold out of Inogen (INGN) in Q2 2019, closing a stake of 2,202 shares — an estimated $210K sold.

Raymond James & Associates first reported a position in INGN in Q3 2015 and held it in 7 quarters. The position peaked at $1.47M in Q3 2018. 197 funds tracked by Wall St. Rank hold INGN as of Q2 2019.

  • Raymond James & Associates reported no remaining Inogen position as of Q2 2019 after selling out during the quarter.
  • Raymond James & Associates sold 2,202 Inogen shares in Q2 2019, an estimated $210K.
  • Raymond James & Associates first reported a position in Inogen in Q3 2015 and held it in 7 quarters.
  • Raymond James & Associates's Inogen position peaked at $1.47M in Q3 2018.
  • 197 funds tracked by Wall St. Rank held Inogen as of Q2 2019.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.